Pasar al contenido principal

BRUCELLOSIS OVINA: VACUNAS SEGURAS Y ESTRATEGIAS DIVA FRENTE A B. MELITENSIS Y B. OVIS

PID2019-107601RB-C31

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CENTRO DE INVESTIGACION Y TECNOLOGIA AGROALIMENTARIA DE ARAGON (CITA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A Brucella melitensis H38¿wbkF rough mutant protects against Brucella ovis in rams

  • Muñoz, Pilar M.
  • Conde-Álvarez, Raquel
  • Andrés-Barranco, Sara
  • de Miguel, María-Jesús
  • Zúñiga-Ripa, Amaia
  • Aragón-Aranda, Beatriz
  • Salvador-Bescós, Miriam
  • Martínez-Gómez, Estrella
  • Iriarte, Maite
  • Barberán, Montserrat
  • Vizcaíno, Nieves
  • Moriyón, Ignacio
  • Blasco, José M.
Brucella melitensis and Brucella ovis are gram-negative pathogens of sheep that cause severe economic losses and, although B. ovis is non-zoonotic, B. melitensis is the main cause of human brucellosis. B. melitensis carries a smooth (S) lipopolysaccharide (LPS) with an N-formyl-perosamine O-polysaccharide (O-PS) that is absent in the rough LPS of B. ovis. Their control and eradication require vaccination, but B. melitensis Rev 1, the only vaccine available, triggers anti-O-PS antibodies that interfere in the S-brucellae serodiagnosis. Since eradication and serological surveillance of the zoonotic species are priorities, Rev 1 is banned once B. melitensis is eradicated or where it never existed, hampering B. ovis control and eradication. To develop a B. ovis specific vaccine, we investigated three Brucella live vaccine candidates lacking N-formyl-perosamine O-PS: Bov::CAΔwadB (CO2-independent B. ovis with truncated LPS core oligosaccharide); Rev1::wbdRΔwbkC (carrying N-acetylated O-PS); and H38ΔwbkF (B. melitensis rough mutant with intact LPS core). After confirming their attenuation and protection against B. ovis in mice, were tested in rams for efficacy. H38ΔwbkF yielded similar protection to Rev 1 against B. ovis but Bov::CAΔwadB and Rev1::wbdRΔwbkC conferred no or poor protection, respectively. All H38ΔwbkF vaccinated rams developed a protracted antibody response in ELISA and immunoprecipitation B. ovis diagnostic tests. In contrast, all remained negative in Rose Bengal and complement fixation tests used routinely for B. melitensis diagnosis, though some became positive in S-LPS ELISA owing to LPS core epitope reactivity. Thus, H38ΔwbkF is an interesting candidate for the immunoprophylaxis of B. ovis in B. melitensis-free areas.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts

  • Blasco, J. M.
  • Moreno, E.
  • Muñoz, P. M.
  • Conde-Álvarez, R.
  • Moriyón, I.
Cattle brucellosis is a severe zoonosis of worldwide distribution caused by Brucella abortus and B. melitensis. In some countries with appropriate infrastructure, animal tagging and movement control, eradication was possible through efficient diagnosis and vaccination with B. abortus S19, usually combined with test-and-slaughter (T/S). Although S19 elicits anti-smooth lipopolysaccharide antibodies that may interfere in the differentiation of infected and vaccinated animals (DIVA), this issue is minimized using appropriate S19 vaccination protocols and irrelevant when high-prevalence makes mass vaccination necessary or when eradication requisites are not met. However, S19 has been broadly replaced by vaccine RB51 (a rifampin-resistant rough mutant) as it is widely accepted that is DIVA, safe and as protective as S19. These RB51 properties are critically reviewed here using the evidence accumulated in the last 35 years. Controlled experiments and field evidence shows that RB51 interferes in immunosorbent assays (iELISA, cELISA and others) and in complement fixation, issues accentuated by revaccinating animals previously immunized with RB51 or S19. Moreover, contacts with virulent brucellae elicit anti-smooth lipopolysaccharide antibodies in RB51 vaccinated animals. Thus, accepting that RB51 is truly DIVA results in extended diagnostic confusions and, when combined with T/S, unnecessary over-culling. Studies supporting the safety of RB51 are flawed and, on the contrary, there is solid evidence that RB51 is excreted in milk and abortifacient in pregnant animals, thus being released in abortions and vaginal fluids. These problems are accentuated by the RB51 virulence in humans, lack diagnostic serological tests detecting these infections and RB51 rifampicin resistance. In controlled experiments, protection by RB51 compares unfavorably with S19 and lasts less than four years with no evidence that RB51-revaccination bolsters immunity, and field studies reporting its usefulness are flawed. There is no evidence that RB51 protects cattle against B. melitensis, infection common when raised together with small ruminants. Finally, data acumulated during cattle brucellosis eradication in Spain shows that S19-T/S is far more efficacious than RB51-T/S, which does not differ from T/S alone. We conclude that the assumption that RB51 is DIVA, safe, and efficaceous results from the uncritical repetition of imperfectly examined evidence, and advise against its use.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Characterization of three predicted zinc exporters in Brucella ovis identifies ZntR-ZntA as a powerful zinc and cadmium efflux system not required for virulence and unveils pathogenic Brucellae heterogeneity in zinc homeostasis

  • Tartilán-Choya, Beatriz
  • Tejedor, Carmen
  • Conde-Álvarez, Raquel
  • Muñoz, Pilar María
  • Vizcaíno, Nieves
Brucella ovis causes non-zoonotic ovine brucellosis of worldwide distribution and is responsible for important economic losses mainly derived from male genital lesions and reproductive fails. Studies about the virulence mechanisms of this rough species (lacking lipopolysaccharide O-chains) are underrepresented when compared to the main zoonotic Brucella species that are smooth (with O-chains). Zinc intoxication constitutes a defense mechanism of the host against bacterial pathogens, which have developed efflux systems to counterbalance toxicity. In this study, we have characterized three potential B. ovis zinc exporters, including the ZntA ortholog previously studied in B. abortus. Despite an in-frame deletion removing 100 amino acids from B. ovis ZntA, the protein retained strong zinc efflux properties. Only indirect evidence suggested a higher exporter activity for B. abortus ZntA, which, together with differences in ZntR-mediated regulation of zntA expression between B. ovis and B. abortus, could contribute to explaining why the ΔzntR mutant of B. abortus is attenuated while that of B. ovis is virulent. Additionally, B. ovis ZntA was revealed as a powerful cadmium exporter contributing to cobalt, copper, and nickel detoxification, properties not previously described for the B. abortus ortholog. Deletion mutants for BOV_0501 and BOV_A1100, also identified as potential zinc exporters and pseudogenes in B. abortus, behaved as the B. ovis parental strain in all tests performed. However, their overexpression in the ΔzntA mutant allowed the detection of discrete zinc and cobalt efflux activity for BOV_0501 and BOV_A1100, respectively. Nevertheless, considering their low expression levels and the stronger activity of ZntA as a zinc and cobalt exporter, the biological role of BOV_0501 and BOV_A1100 is questionable. Results presented in this study evidence heterogeneity among pathogenic Brucellae regarding zinc export and, considering the virulence of B. ovis ΔzntA, suggest that host-mediated zinc intoxication is not a relevant mechanism to control B. ovis infection.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A Review on the Methodology and Use of the Pregnant Mouse Model in the Study of Brucella Reproductive Pathogenesis and Its Abortifacient Effect

  • Elizalde-Bielsa, Aitor
  • Muñoz, Pilar M.
  • Zúñiga-Ripa, Amaia
  • Conde-Álvarez, Raquel
Brucellosis is one of the most common and widespread bacterial zoonoses and is caused by Gram-negative bacteria belonging to the genus Brucella. These organisms are able to infect and replicate within the placenta, resulting in abortion, one of the main clinical signs of brucellosis. Although the mouse model is widely used to study Brucella virulence and, more recently, to evaluate the protection of new vaccines, there is no clear consensus on the experimental conditions (e.g., mouse strains, doses, routes of inoculation, infection/pregnancy time) and the natural host reproducibility of the pregnant mouse model for reproductive brucellosis. This lack of consensus calls for a review that integrates the major findings regarding the effect of Brucella wild-type and vaccine strains infections on mouse pregnancy. We found sufficient evidence on the utility of the pregnant mouse model to study Brucella-induced placentitis and abortion and propose suitable experimental conditions (dose, time of infection) and pregnancy outcome readouts for B. abortus and B. melitensis studies. Finally, we discuss the utility and limitations of the pregnant mouse as a predictive model for the abortifacient effect of live Brucella vaccines.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while minimizing serological interference

  • Lopez, Nerea
  • Andrés-Barranco, Sara
  • Miguel, M. Jesús de
  • Zúñiga-Ripa, Amaia
  • Elizalde-Bielsa, Aitor
  • Salvador-Bescós, Miriam
  • Iriarte, Maite
  • Barberán, Montserrat
  • Blasco, José María
  • Moriyón, Ignacio
  • Conde-Álvarez, Raquel
  • Muñoz, Pilar M.
Sheep brucellosis is a reproductive disease caused by Brucella melitensis and B. ovis, Gram-negative bacteria that differ in surface antigens: B. melitensis carries a smooth (S) lipopolysaccharide (LPS) with a characteristic O-polysaccharide (O-PS), while B. ovis bears a rough (R) LPS lacking O-PS. Only the former is zoonotic and of public health concern, but both cause significant economic losses, thus requiring effective vaccines. The sole vaccine available, B. melitensis Rev1, protects against both infections but induces antibodies detected by S-LPS-based tests used for B. melitensis surveillance. Since controlling this zoonotic species is a priority, Rev1 is banned in B. melitensis-free areas. Consequently, B. ovis (detected by R-LPS-based tests) remains endemic or re-emerges, and an R brucellosis vaccine is needed. Previously, we demonstrated that subcutaneous vaccination with B. melitensis R mutant H38ΔwbkF protects rams against B. ovis similarly to Rev1, without interfering in the official S-LPS-based Rose Bengal and Complement Fixation tests. However, H38ΔwbkF elicits R-LPS antibodies that interfere with B. ovis tests. Here, we explored two strategies to minimize this interference: (i) altering H38ΔwbkF relevant diagnostic epitopes by constructing wadB and wadC mutants deleted in sugars of the R-LPS core tetrasaccharide branch; and (ii) administering H38ΔwbkF conjunctivally, a route known to reduce antibody responses to S brucellosis vaccines. While the core-defective mutants were over-attenuated and failed to protect mice, the conjunctival route preserved H38ΔwbkF efficacy in rams and significantly reduced serological interference. Conjunctival H38ΔwbkF vaccine is thus a suitable tool for B. ovis eradication in B. melitensis-free areas.
citaREA. Repositorio Institucional del CITA
Publicación Artículo científico (JournalArticle)

Disruption of the Nitric Oxide Reductase Operon via norD Deletion Does Not Affect Brucella abortus 2308W Virulence

  • Rasheed, Faisal
  • Zúñiga Ripa, Amaia
  • Salvador Bescós, Miriam
  • Irshad, Hamid
  • Peña Villafruela, Raquel
  • Muñoz Álvaro, Pilar María
  • Miguel López, María Jesús de
  • Ali, Qurban
  • Conde Álvarez, Raquel
  • Khan, Saeed-ul-Hassan
Brucella are intracellular pathogens that use flexible respiratory strategies to adapt to oxygen-limited conditions. The nor operon encodes components of nitric oxide reductase (Nor), which are involved in denitrification and nitric oxide (NO) detoxification. In this study, the role of the norD gene in nitrate-dependent respiration, resistance to nitrosative stress, and intracellular persistence in B. abortus was evaluated. A non-polar ΔnorD mutant was generated in strain 2308W and its survival and growth under aerobic and anaerobic conditions, with and without nitrate, as well as its tolerance to NO donors, were analyzed. In addition, its behavior was evaluated in activated and non-activated murine RAW264.7 and human THP-1 macrophages and in a murine infection model. The deletion of norD did not affect viability or growth under any of the conditions tested, nor did it alter resistance to NO in vitro or within activated macrophages. Furthermore, the mutant showed virulence comparable to the wild-type strain in BALB/c mice. These results contrast with those described for other Brucella species, suggesting that norD is dispensable in B. abortus 2308W virulence and that in the Brucella genus, there are species-specific differences in the role of the nor operon during infection., Esta investigación ha sido financiada por MCIN/AEI/10.1303910.13039/501100011033 y FEDER, UE en el marco de los proyectos PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 y PID2019-107601RA-C32. La estancia de F.R. en la Universidad de Navarra fue financiada por la Comisión de Educación Superior de Pakistán. R.P.-V. es beneficiario de la beca de doctorado financiada por PREP2023-000737. El trabajo de P.M.M. y M.J.d.M. (CITA) también contó con el apoyo del Gobierno de Aragón (Grupo de Investigación A21_23R)., Si
citaREA. Repositorio Institucional del CITA
Publicación

Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while minimizing serological interference

  • López Fernández, Nerea
  • Andrés Barranco, Sara
  • Miguel López, María Jesús de
  • Zúñiga Ripa, Amaia
  • Elizalde Bielsa, Aitor
  • Salvador Bescós, Miriam
  • Iriarte, Maite
  • Barberán Pelegrín, Montserrat
  • Blasco Martínez, José María
  • Moriyón Uria, Ignacio
  • Conde Álvarez, Raquel
  • Muñoz Álvaro, Pilar María
Sheep brucellosis is a reproductive disease caused by Brucella melitensis and B. ovis, Gram-negative bacteria that differ in surface antigens: B. melitensis carries a smooth (S) lipopolysaccharide (LPS) with a characteristic O-polysaccharide (O-PS), while B. ovis bears a rough (R) LPS lacking O-PS. Only the former is zoonotic and of public health concern, but both cause significant economic losses, thus requiring effective vaccines. The sole vaccine available, B. melitensis Rev1, protects against both infections but induces antibodies detected by S-LPS-based tests used for B. melitensis surveillance. Since controlling this zoonotic species is a priority, Rev1 is banned in B. melitensis-free areas. Consequently, B. ovis (detected by R-LPS-based tests) remains endemic or re-emerges, and an R brucellosis vaccine is needed. Previously, we demonstrated that subcutaneous vaccination with B. melitensis R mutant H38ΔwbkF protects rams against B. ovis similarly to Rev1, without interfering in the official S-LPS-based Rose Bengal and Complement Fixation tests. However, H38ΔwbkF elicits R-LPS antibodies that interfere with B. ovis tests. Here, we explored two strategies to minimize this interference: (i) altering H38ΔwbkF relevant diagnostic epitopes by constructing wadB and wadC mutants deleted in sugars of the R-LPS core tetrasaccharide branch; and (ii) administering H38ΔwbkF conjunctivally, a route known to reduce antibody responses to S brucellosis vaccines. While the core-defective mutants were over-attenuated and failed to protect mice, the conjunctival route preserved H38ΔwbkF efficacy in rams and significantly reduced serological interference. Conjunctival H38ΔwbkF vaccine is thus a suitable tool for B. ovis eradication in B. melitensis-free areas., Esta investigación se ha llevado a cabo en el marco de los proyectos PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 y PID2019-107601RA-C32 financiados por MCIN/AEI/10.1303910.13039/501100011033 y por el FEDER, UE. El trabajo de P.M.M., S.A.B. y M.J.d.M. (CITA) también contó con el apoyo del Gobierno de Aragón (Grupo de Investigación A21_23R). N.L. fue beneficiario de la beca de doctorado financiada por PRE2020-093859., No
citaREA. Repositorio Institucional del CITA
Publicación

Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while reducing the diagnostic interference of vaccine antibodies

  • López Fernández, Nerea
  • Andrés Barranco, Sara
  • Miguel López, María Jesús de
  • Salvador Bescós, M.
  • Zúñiga Ripa, Amaia
  • Iriarte, Maite
  • Blasco Martínez, José María
  • Moriyón Uria, Ignacio
  • Conde Álvarez, Raquel
  • Muñoz Álvaro, Pilar María
AIM OF THIS WORK: To evaluate the use of the conjunctival route as a strategy to reduce the persistence of H38ΔwbkF vaccine antibodies while maintaining protection against B. ovis., Research supported by MCIN/AEI (projects PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 and PID2019107601RA-C32), Aragón Goverment (A23-21R) and REPRODIVAC / Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact from the EU Horizon research and innovation program under Grant Agreement No. 101060313. Acknowledgements: Sara Serrano for her excellent technical assistant.
citaREA. Repositorio Institucional del CITA
Publicación Contribución de congreso (ConferenceOutput)

Evaluation of cross-protection and virulence profiles of Brucella suis biovar 2 vaccine candidates

  • López Fernández, Nerea
  • Miguel López, María Jesús de
  • López Fernández, Nerea
  • Zúñiga Ripa, Amaia
  • Salvador Bescós, Miriam
  • Elizalde Bielsa, Aitor
  • Iriarte, Maite
  • Moriyón Uria, Ignacio
  • Muñoz Álvaro, Pilar María
  • Conde Álvarez, Raquel